论文信息 - MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies - 字舞流文

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies

S. Mazumder | A. Almasan | E. Hsi | B. Hill | J. Bodo | G. Choudhary | S. Al-harbi | M. Smith | S. Mazumder | M. Smith | Sayer Al-harbi | Eric D. Hsi | Gaurav S. Choudhary | Brian T. Hill | Mitchell R. Smith | G. S. Choudhary